Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

Clinical trial NCT06571396 · RECRUITING

Trial details

NCT number: NCT06571396
Sponsor: Qilu Hospital of Shandong University
Status: RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Hepatocellular Immunotherapy

Start date: 2014-04-01
Primary completion: 2025-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.